Tag: Zoya Brar
Decoding the role of Genomic Testing for Precision Oncology
For patients considering genomic testing, engaging in an open conversation with their healthcare team is critical, writes Zoya Brar, Founder, CORE Diagnostics
BioVoice eMagazine June 2023 | Issue 6 | Volume 4
This edition tracks the latest scenario in Indian CRO industry and analyzes whether India can become a hotspot for clinical trials. Key highlights include Expert Insights by Dr Cyrus Karkaria, President- Biotechnology, Lupin and Zoya Brar, Founder, CORE Diagnostics.
Dinesh Chauhan steps up as CEO of CORE Diagnostics, Zoya Brar...
The current Chief Operating Officer of CORE Diagnostics, Dinesh Chauhan will be stepping up as the Chief Executive Officer starting September 1st, 2020 while Zoya Brar, the current CEO and the Founder of the company is moving on and will also resign from the board................
COVID-19 testing starts at CORE Diagnostics Gurgaon lab
To ensure zero contamination of the samples, CORE Diagnostics has setup a separate facility within its high-end Gurgaon lab to perform the confirmatory polymerase chain reaction-based (PCR) COVID-19 test with all strains that are approved by the Government of India.....................
“Diagnostics sector in India is poised for a sharp growth”
In an exclusive interaction with the BioVoice, Zoya Brar, Founder and Managing Director of CORE Diagnostics shared details about the company's journey so far, its vision, market dynamics and much more. Read on..........................
Illumina’s executive chairman talks about precision medicine at CORE Diagnostics meet
Mr Jay Flatley who serves as the Executive Chairman of the Board of Directors, Illumina emphasized on the need for large-scale population study with an Indian cohort as the much needed next step in understanding disease patterns that are specific to people of Indian origin...……...
CORE Diagnostics launches nephroCORE to target kidney disease
CORE’s new addition of nephrology related diagnostic tests comprises of advanced nephro-pathology services, molecular testing for rare and inherited (genetic) kidney diseases, screening for pre and post-transplant infectious diseases, monitoring drug levels, and Transplant Immunology..............
“Being realistic about our capabilities, we always believe in partnerships”
Mentioned Ms Zoya Brar, Founder and Managing Director, Core Diagnostics in an exclusive interaction with the BioVoice, where she talked about latest initaitives and future outlook...........
Findings presented by CORE Diagnostics to help treat cancer
Results presented by CORE Diagnostics in the field of radiotherapy for treating cancer captured the attention of around 300 oncologists from 16 organizations that were present at the event..........
CORE Diagnostics teams up with Canada’s Contextual Genomics
Contextual Genomics's 'Find It' that screens for 120 genetic mutations in cancer patients, will be exclusively marketed in India by the CORE Diagnostics under a new name, 'geneCORE Hotspot'...........